Regeneron Pharmaceuticals/ US75886F1075 /
2025-03-17 8:59:54 PM | Chg. +11.59 | Volume | Bid9:25:00 PM | Ask9:25:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
678.09USD | +1.74% | 55,877 Turnover: 17.46 mill. |
-Bid Size: - | -Ask Size: - | 74.17 bill.USD | - | 16.59 |
Business description
Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases.
Management board & Supervisory board
CEO |
---|
Dr. Leonard S. Schleifer |
Management board |
Robert E. Landry, Dr. George D. Yancopoulos |
Supervisory board |
Arthur F. Ryan, Christine A. Poon, Craig B. Thompson, Dr. Bonnie L. Bassler, Dr. George D. Yancopoulos, Dr. Leonard S. Schleifer, Dr. Marc Tessier-Lavigne, George L. Sing, Huda Y. Zoghbi, M.D., Joseph L. Goldstein, M.D., Michael S. Brown, M.D., Tony Coles, M.D. |
Company data
Name: | Regeneron Pharmaceuticals Inc. |
Address: | 777 Old Saw Mill River Road,Tarrytown, New York 10591-6707, USA |
Phone: | +1-914-847-7000 |
Fax: | - |
E-mail: | - |
Internet: | is.gd/sEAmh8 |
Industry: | Biotechnology |
Sector: | Biotechnology |
Sub sector: | Biotechnology |
End of financial year: | 12-31 |
Free Float: | 68.40% |
IPO date: | 1991-04-12 |
Investor relations
Name: | - |
IR phone: | +1-914-847-7741 |
IR Fax: | - |
IR e-mail: | invest@regeneron.com |
Company calendar
CW 12 | 2025-03-20 Dividend Payment |
Main Shareholders
Others | 65.51% | |
Vanguard Group Inc | 10.28% | |
Blackrock Inc. | 8.88% | |
State Street Corporation | 4.84% | |
Geode Capital Management, LLC | 2.51% | |
Morgan Stanley | 1.75% | |
Norges Bank Investment Management | 1.60% | |
Amundi | 1.32% | |
Northern Trust Corporation | 1.20% | |
Others | 2.11% |
Regeneron Pharmaceuticals/ US75886F1075 /
2025-03-17 7:59:54 PM | Chg. +11.59 | Volume | Bid8:25:00 PM | Ask8:25:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
678.09USD | +1.74% | 55,877 Turnover: 17.46 mill. |
-Bid Size: - | -Ask Size: - | 74.17 bill.USD | - | 16.59 |
Master data
WKN: | 881535 |
---|---|
Ticker: | REGN |
Currency: | USD |
Type: | Stock |
Issue type: | Common stock |
Trading segment: | - |
Next exchange holiday: | 2025-04-18 |
Indices: Nasdaq 100, baha us 500, baha us tech 100 |
Quote data
Open: | 669.34 |
---|---|
High: | 679.17 |
Low: | 666.74 |
Previous Close: | 666.50 |
Volume (shares): | 55,877 |
Turnover: | 17.46 mill. |
Trades: | 227 |
Market phase: | - |
All quotes in USD
Latest news
Performance
1 Week | -9.04% | ||
---|---|---|---|
1 Month | +0.70% | ||
3 Months | -8.38% | ||
YTD | -4.80% | ||
1 Year | -29.39% | ||
3 Years | -1.08% | ||
5 Years | +37.82% | ||
10 Years | +44.83% |
1W High / 1W Low: | 745.47 | 666.50 |
---|---|---|
1M High / 1M Low: | 745.47 | 666.50 |
6M High / 6M Low: | 1,150.30 | 663.23 |
High (YTD): | 2025-03-10 | 745.47 |
Low (YTD): | 2025-02-12 | 663.23 |
52W High: | 2024-08-27 | 1,200.03 |
52W Low: | 2025-02-12 | 663.23 |
Avg. price 1W: | 699.99 | |
Avg. volume 1W: | 36,961.40 | |
Avg. price 1M: | 697.98 | |
Avg. volume 1M: | 26,358.84 | |
Avg. price 6M: | 802.18 | |
Avg. volume 6M: | 28,737.74 | |
Avg. price 1Y: | 918.76 | |
Avg. volume 1Y: | 22,030.73 | |
Volatility 1M: | 37.09% | |
Volatility 6M: | 30.35% | |
Volatility 1Y: | 25.31% | |
Volatility 3Y: | 27.24% | |
Dividend per Share: | - | |
Earnings per Share: | 40.90 USD | |
Return on Equity: | 15.03% | |
Dividend Yield: | - | |
P/E Ratio: | 16.59 | |
Market Capitalization: | 74.17 bill. USD | |
Free Float Market Cap.: | - |
You are using the free license of baha.com exclusively for private, non-commercial use. For professional users we offer the baha WebStation, contact us to arrange a demo.
Create a free account, or log in
Once registered, you can:
- Continue using baha.com with no limitations
- Create wachlists, portfolios and alerts
- Use our revolutionary app to access all baha.com features on the go.